← Leaderboards
Michelle (micki) E Washburn
Innatevr, Llc
$565,117
Attributed
$728,367
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $416.8K · FY2021–23$500K$375K$250K$125K$0
'21
'22
'23
Funding mix
By agency
NIH$638,080 · 2
AHRQ$90,287 · 1
By mechanism
R44$326,500 · 1
R41$311,580 · 1
R03$90,287 · 1
Top collaborators
- Paul Ziemba1 shared
Others in their field
Other Emerging Leaders on “Opioid Use Disorder”
- Chanza Baytop · Westat, Inc.$271,217,917
- Andrew S Huhn · Johns Hopkins University$19,514,484
- Jeffrey Reich · Sparian Biosciences, Inc.$15,164,944
- Nikej Shah · Nirsum Laboratories, Inc.$12,588,496
- Meredith C. B. Adams · Medical College Of Wisconsin$12,171,750
- Richard Scranton · Lyndra Therapeutics, Inc.$12,106,230
Research focus
Opioid Use DisorderSubstance MisuseImpairmentNeonatal Abstinence SyndromePublic HealthRelapseAcuteHiv/HcvLeftMortalityEmergency CarePhysical ConditioningEnvironmentExposure ToChild WelfareChronicBehavioralDesignCravingJusticeCuesMental HealthComputer SoftwareSubstance Use
Grant awards (4)
Modular Virtual Reality Therapeutic for Opioid and Stimulant Use Disorders$326,500
R44 · FY2023 · DA
A Systematic Review and Meta-analysis on the Effectiveness of Home Visiting Programs on Postpartum Depression$90,287
R03 · FY2023 · HS · contact PI
Modular Adaptive Virtual Reality Intervention for Clinical Substance use disorder (MAVRICS)$55,000
R41 · FY2022 · DA · contact PI
Modular Adaptive Virtual Reality Intervention for Clinical Substance use disorder (MAVRICS)$256,580
R41 · FY2021 · DA · contact PI